Suppr超能文献

用于对抗的新型药物递送系统:简要综述。

Novel Drug Delivery Systems for Combating : A Brief Review.

作者信息

Iman M, Mirfakhraee S

机构信息

Department of Pharmaceutics, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran.

出版信息

Arch Razi Inst. 2024 Oct 31;79(5):903-914. doi: 10.32592/ARI.2024.79.5.903. eCollection 2024 Oct.

Abstract

It is well established that infection is a primary cause of gastritis. There is an alarming potential for this infection to progress into gastric cancer if left unaddressed. However, the efficacy of conventional treatments is undermined by the growing challenge of antibiotic resistance and the necessity for complex multidrug and high-dose therapeutic regimens. Furthermore, the presence of factors such as biofilm formation, efflux pumps, and gene mutations significantly elevates the risk of treatment failure. In view of these significant challenges, contemporary drug delivery systems represent a vital adjunct in the battle against . These advanced and sophisticated systems offer significant advantages, including enhanced drug protection, controlled release, and targeted delivery to specific tissues. Nanoparticles, in particular, show promise in combating infection through a variety of mechanisms, including direct drug delivery into the bacteria and the destruction of bacterial walls, as well as generation of free radicals. This review provides an overview of the current therapeutic landscape, including both existing and evolving treatment options. It delves into the transformative potential of novel drug delivery systems, including micro- and nanoparticles, to play a transformative role in the complex field of infection treatment. By examining the complex relationship between infection dynamics and cutting-edge delivery technologies, this review seeks to identify avenues for more effective and targeted interventions against this persistent threat. As our understanding of infection advances, new treatments and enhanced drug delivery methods offer the prospect of a more effective and personalized approach to combating this persistent health problem. This dynamic intersection of microbiology and nanotechnology exemplifies the relentless pursuit of innovative solutions to safeguard against the formidable challenges posed by . Ultimately, it offers hope for improved patient outcomes and a healthier population.

摘要

众所周知,感染是胃炎的主要病因。如果不加以治疗,这种感染发展成胃癌的可能性令人担忧。然而,抗生素耐药性的不断增加以及复杂的多药和高剂量治疗方案的必要性削弱了传统治疗的效果。此外,生物膜形成、外排泵和基因突变等因素的存在显著增加了治疗失败的风险。鉴于这些重大挑战,当代药物递送系统是对抗[此处原文缺失具体疾病名称]的重要辅助手段。这些先进而精密的系统具有显著优势,包括增强药物保护、控释以及靶向递送至特定组织。特别是纳米颗粒,通过多种机制在对抗[此处原文缺失具体疾病名称]感染方面显示出前景,包括将药物直接递送至细菌内、破坏细菌细胞壁以及产生自由基。本综述概述了当前的治疗格局,包括现有的和不断发展的治疗选择。它深入探讨了新型药物递送系统(包括微米和纳米颗粒)在复杂的[此处原文缺失具体疾病名称]感染治疗领域发挥变革性作用的潜力。通过研究感染动态与前沿递送技术之间的复杂关系,本综述旨在确定针对这一持续威胁的更有效和靶向干预途径。随着我们对[此处原文缺失具体疾病名称]感染的认识不断深入,新的治疗方法和改进的药物递送方法为对抗这一持续存在 的健康问题提供了更有效和个性化方法的前景。微生物学和纳米技术的这种动态交叉体现了对创新解决方案的不懈追求,以防范[此处原文缺失具体疾病名称]带来的巨大挑战。最终,它为改善患者预后和实现更健康的人群带来了希望。

相似文献

1
Novel Drug Delivery Systems for Combating : A Brief Review.
Arch Razi Inst. 2024 Oct 31;79(5):903-914. doi: 10.32592/ARI.2024.79.5.903. eCollection 2024 Oct.
2
An overview of nanotechnology-based treatment approaches against Helicobacter Pylori.
Expert Rev Anti Infect Ther. 2019 Oct;17(10):829-840. doi: 10.1080/14787210.2019.1677464. Epub 2019 Oct 16.
4
Combatting with oral nanomedicines.
J Mater Chem B. 2021 Dec 15;9(48):9826-9838. doi: 10.1039/d1tb02038b.
5
Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem.
Helicobacter. 2016 Oct;21(5):349-63. doi: 10.1111/hel.12299. Epub 2016 Jan 29.
6
Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment of infections.
Crit Rev Microbiol. 2021 Aug;47(4):435-460. doi: 10.1080/1040841X.2021.1895721. Epub 2021 Mar 16.
7
Nanomaterials: A Prospective Strategy for Biofilm-Forming Treatment.
Int J Nanomedicine. 2025 Apr 23;20:5209-5229. doi: 10.2147/IJN.S512066. eCollection 2025.
8
The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection.
Expert Rev Anti Infect Ther. 2014 Aug;12(8):981-92. doi: 10.1586/14787210.2014.930663. Epub 2014 Jun 30.
9
Microparticles and nanoparticles-based approaches to improve oral treatment of infection.
Crit Rev Microbiol. 2024 Sep;50(5):728-749. doi: 10.1080/1040841X.2023.2274835. Epub 2023 Oct 28.
10
Gastroretentive drug delivery systems for the treatment of Helicobacter pylori.
World J Gastroenterol. 2014 Jul 28;20(28):9321-9. doi: 10.3748/wjg.v20.i28.9321.

本文引用的文献

2
Antibacterial and antibiofilm activity of mannose-modified chitosan/PMLA nanoparticles against multidrug-resistant Helicobacter pylori.
Int J Biol Macromol. 2022 Dec 31;223(Pt A):418-432. doi: 10.1016/j.ijbiomac.2022.10.265. Epub 2022 Nov 7.
5
Antibiotics-free nanoparticles eradicate Helicobacter pylori biofilms and intracellular bacteria.
J Control Release. 2022 Aug;348:370-385. doi: 10.1016/j.jconrel.2022.05.044. Epub 2022 Jun 9.
9
Bacteria-targeting chitosan/carbon dots nanocomposite with membrane disruptive properties improve eradication rate of .
J Biomater Sci Polym Ed. 2021 Dec;32(18):2423-2447. doi: 10.1080/09205063.2021.1972559. Epub 2021 Oct 23.
10
Unraveling the Novel Effect of Patchouli Alcohol Against the Antibiotic Resistance of .
Front Microbiol. 2021 Jun 2;12:674560. doi: 10.3389/fmicb.2021.674560. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验